JP2000506968A - 液体混合物の製造法 - Google Patents
液体混合物の製造法Info
- Publication number
- JP2000506968A JP2000506968A JP9530859A JP53085997A JP2000506968A JP 2000506968 A JP2000506968 A JP 2000506968A JP 9530859 A JP9530859 A JP 9530859A JP 53085997 A JP53085997 A JP 53085997A JP 2000506968 A JP2000506968 A JP 2000506968A
- Authority
- JP
- Japan
- Prior art keywords
- mixture
- salt
- liquid
- ionic strength
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 239000007788 liquid Substances 0.000 title claims abstract description 48
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- 238000000034 method Methods 0.000 claims abstract description 70
- 150000003839 salts Chemical class 0.000 claims abstract description 62
- 239000002253 acid Substances 0.000 claims abstract description 15
- 239000002904 solvent Substances 0.000 claims abstract description 9
- 239000000243 solution Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000012266 salt solution Substances 0.000 claims description 9
- 238000004811 liquid chromatography Methods 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 238000004255 ion exchange chromatography Methods 0.000 claims description 4
- 238000013375 chromatographic separation Methods 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 239000000872 buffer Substances 0.000 abstract description 43
- 230000008859 change Effects 0.000 abstract description 11
- 238000000926 separation method Methods 0.000 description 31
- 102000004169 proteins and genes Human genes 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 24
- 238000012937 correction Methods 0.000 description 21
- 238000010828 elution Methods 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 239000007853 buffer solution Substances 0.000 description 11
- 238000004587 chromatography analysis Methods 0.000 description 10
- 238000005457 optimization Methods 0.000 description 10
- 238000012216 screening Methods 0.000 description 8
- 238000005571 anion exchange chromatography Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000005277 cation exchange chromatography Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 102000016943 Muramidase Human genes 0.000 description 4
- 108010014251 Muramidase Proteins 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 150000002500 ions Chemical group 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 235000010335 lysozyme Nutrition 0.000 description 4
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010058846 Ovalbumin Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000004338 Transferrin Human genes 0.000 description 3
- 108090000901 Transferrin Proteins 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000006193 liquid solution Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229940092253 ovalbumin Drugs 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000012581 transferrin Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 108010038061 Chymotrypsinogen Proteins 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000007989 BIS-Tris Propane buffer Substances 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HHKZCCWKTZRCCL-UHFFFAOYSA-N bis-tris propane Chemical compound OCC(CO)(CO)NCCCNC(CO)(CO)CO HHKZCCWKTZRCCL-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Seasonings (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.(i)1個またはそれ以上の緩衝種; (ii)二者択一的に酸または塩; (iii)所望により塩;そして (iv)溶媒 ここで、成分(i)から(iv)の比率は、各時点で混合物の予め選択されたpHを得 るために、液体混合物のpHとイオン強度の相互関係を考慮に入れて、同時に変 化するものである、液体混合物の製造法。 基本にした反復法を使用することを特徴とする、請求項1記載の方法。 3.反復法が り、一定の塩濃度を有する請求項1で定義の混合物の異なるプロトン性成分の比 率を計算し、ここで、該混合物のイオン強度は、該塩の存在によってのみ考慮さ れる; (b)前記段階で計算された比率を基にして、混合物の得られるイオン強度を計算 する; に入れて、混合物の予め選択されたpHでの混合物のプロトン性成分の新セット の比率を計算する;そして (d)最後のセットで見られたプロトン性成分の比率の値と、直前の段階で見られ た値の偏差が予め定義した最大レベルを超えなくなるまで段階(b)および(c)を 繰り返し、この比率の最後のセットが次いで一定塩濃度での選択されたpHの混 合物を製造するものとして維持する 段階を含むことを特徴とする、請求項2記載の方法。 4.液体混合物の成分(i)から(iv)を別々の液体として提供することを特徴と する、請求項3記載の方法。 5.溶媒が蒸留および/または脱イオン水であることを特徴とする、請求項1 から4のいずれかに記載の方法。 6.塩が不活性塩であることを特徴とする、請求項1から5のいずれかに記載 の方法。 7.請求項1から6のいずれかの方法で得られることを特徴とする、液体混合 物。 8.液体流を、好ましくは請求項3記載の方法により操作される計量デバイス の手段により、(i)から(iv)の該溶液を供給することにより得ることを特徴とす る、一定pHおよび可変イオン強度の液体流の製造法。 9.溶出液流として、請求項8で製造された液体流を使用する、液体クロマト グラフィー法。 10.イオン交換クロマトグラフィーであることを特徴とする、請求項9記載 の方法。 11.計量デバイスが請求項3の方法により操作されていることを特徴とする 、請求項1から10のいずれかに記載の成分(i)から(iv)をクロマトグラフィー 分離デバイスに供給できる、オンライン計量デバイスを含む、液体クロマトグラ フィー装置。 12.2つのポンプを含み、1つが緩衝種溶液および酸(または塩基)溶液を供 給するために配置され、他方が溶媒および随意の塩溶液を供給するために配置さ れていることを特徴とする、請求項11記載の装置。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9600796A SE9600796D0 (sv) | 1996-02-29 | 1996-02-29 | A method of preparing a liquid mixture |
| SE9600796-8 | 1996-02-29 | ||
| PCT/SE1997/000301 WO1997031692A1 (en) | 1996-02-29 | 1997-02-24 | A method of preparing a liquid mixture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000506968A true JP2000506968A (ja) | 2000-06-06 |
| JP2000506968A5 JP2000506968A5 (ja) | 2004-11-25 |
Family
ID=20401618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9530859A Ceased JP2000506968A (ja) | 1996-02-29 | 1997-02-24 | 液体混合物の製造法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6221250B1 (ja) |
| EP (1) | EP0883428B1 (ja) |
| JP (1) | JP2000506968A (ja) |
| AT (1) | ATE264129T1 (ja) |
| DE (1) | DE69728656T2 (ja) |
| DK (1) | DK0883428T3 (ja) |
| SE (1) | SE9600796D0 (ja) |
| WO (1) | WO1997031692A1 (ja) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011518328A (ja) * | 2008-04-21 | 2011-06-23 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体混合物の調製 |
| JP2013506128A (ja) * | 2009-09-25 | 2013-02-21 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体混合物の調製方法及びシステム |
| JP2013529781A (ja) * | 2010-06-23 | 2013-07-22 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体混合物の製造方法 |
| JP2014501385A (ja) * | 2010-12-17 | 2014-01-20 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体混合物の導電率を予測する方法 |
| WO2018042529A1 (ja) * | 2016-08-31 | 2018-03-08 | 株式会社島津製作所 | 液体クロマトグラフ分析装置の制御装置、液体クロマトグラフ分析装置の制御方法、および、液体クロマトグラフ分析システム |
| JP2020536252A (ja) * | 2017-10-04 | 2020-12-10 | フジフィルム・ダイオシンス・バイオテクノロジーズ ・ユーケイ・リミテッド | 既定のpHの水溶液を調製するための方法 |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6379973B1 (en) * | 1999-03-05 | 2002-04-30 | The United States Of America As Represented By The Department Of Health And Human Services | Chromatographic separation apparatus and method |
| WO2005040787A1 (en) * | 2003-10-17 | 2005-05-06 | Ge Healthcare Bio-Sciences Ab | Chromatography system, method and software for the separation of biomolecules |
| US8652334B2 (en) * | 2004-08-12 | 2014-02-18 | Lipoxen Technologies Limited | Fractionation of charged polysaccharide |
| US20070034572A1 (en) * | 2005-08-09 | 2007-02-15 | The Procter & Gamble Company | Low pressure anion chromatographic apparatus and method having two or more eluents |
| JP2010502960A (ja) * | 2006-08-29 | 2010-01-28 | クライオバイオフィジカ,インコーポレイテッド | 液体クロマトグラフィー用の多成分、同時、独立多勾配システム |
| US9643103B2 (en) | 2010-05-26 | 2017-05-09 | Waters Technologies Corporation | Process for preparing liquid mixtures of known pH and salt concentration |
| US10422776B2 (en) * | 2014-05-09 | 2019-09-24 | Waters Technologies Corporation | Methods for preparing liquid mixtures |
| WO2016066579A1 (en) | 2014-10-30 | 2016-05-06 | Ge Healthcare Bio-Sciences Ab | METHOD FOR PREDICTING THE DYNAMIC pH RANGE OF A BUFFER |
| GB2536703B (en) * | 2015-03-27 | 2020-12-02 | Ge Healthcare Bio Sciences Ab | Method for baseline correction in a chromatogram |
| US12158453B2 (en) | 2019-02-28 | 2024-12-03 | Cytiva Sweden Ab | Control of a buffer preparation process |
| US11022585B2 (en) * | 2019-06-09 | 2021-06-01 | Dionex Corporation | Methods and systems for optimizing buffer conditions with liquid chromatography |
| US12576006B2 (en) | 2020-09-22 | 2026-03-17 | Alphinity Usa, Inc. | Systems and methods for the preparation of fluids for bioprocess and pharmaceutical applications |
| WO2024240745A1 (en) | 2023-05-25 | 2024-11-28 | Cytiva Sweden Ab | System and method for preparation of a buffer liquid |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3615170A (en) * | 1969-12-03 | 1971-10-26 | Molybdenum Corp | Process for separating metals using double solvent extraction with bridging solvent medium |
| US3712513A (en) * | 1970-05-12 | 1973-01-23 | Du Pont | Apparatus and method for gradient elution |
| DE3211309A1 (de) * | 1982-03-26 | 1983-09-29 | Metin Dipl.-Ing. 6100 Darmstadt Colpan | Chromatographisches verfahren zur isolierung von makromolekuelen |
| JPH0789951B2 (ja) * | 1986-06-18 | 1995-10-04 | 財団法人阪大微生物病研究会 | 遺伝子発現産物の精製法 |
| US5340731A (en) * | 1988-07-08 | 1994-08-23 | University Of British Columbia | Method of preparing a B-1,4 glycan matrix containing a bound fusion protein |
| GB2230967B (en) * | 1989-04-20 | 1993-12-08 | Philips Electronic Associated | Liquid chromatography |
| US5209853A (en) * | 1989-04-20 | 1993-05-11 | U.S. Philips Corporation | Liquid chromatography |
| SE502488C2 (sv) * | 1990-07-31 | 1995-10-30 | Essum Ab | Metod och anordning för framställning av gradienter |
| IL101356A (en) * | 1991-04-03 | 1996-08-04 | Perkin Elmer Corp | Solvents for the separation of nucleic acids by replacing anions |
| US5714320A (en) * | 1993-04-15 | 1998-02-03 | University Of Rochester | Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides |
| US5531791A (en) * | 1993-07-23 | 1996-07-02 | Bioscience Consultants | Composition for repair of defects in osseous tissues, method of making, and prosthesis |
| US5610285A (en) * | 1994-08-24 | 1997-03-11 | Bayer Corporation | Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions |
-
1996
- 1996-02-29 SE SE9600796A patent/SE9600796D0/xx unknown
-
1997
- 1997-02-24 DE DE69728656T patent/DE69728656T2/de not_active Expired - Fee Related
- 1997-02-24 EP EP97906372A patent/EP0883428B1/en not_active Expired - Lifetime
- 1997-02-24 AT AT97906372T patent/ATE264129T1/de not_active IP Right Cessation
- 1997-02-24 WO PCT/SE1997/000301 patent/WO1997031692A1/en not_active Ceased
- 1997-02-24 JP JP9530859A patent/JP2000506968A/ja not_active Ceased
- 1997-02-24 DK DK97906372T patent/DK0883428T3/da active
- 1997-02-24 US US09/125,919 patent/US6221250B1/en not_active Expired - Lifetime
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011518328A (ja) * | 2008-04-21 | 2011-06-23 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体混合物の調製 |
| JP2013506128A (ja) * | 2009-09-25 | 2013-02-21 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体混合物の調製方法及びシステム |
| JP2013529781A (ja) * | 2010-06-23 | 2013-07-22 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体混合物の製造方法 |
| JP2014501385A (ja) * | 2010-12-17 | 2014-01-20 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体混合物の導電率を予測する方法 |
| WO2018042529A1 (ja) * | 2016-08-31 | 2018-03-08 | 株式会社島津製作所 | 液体クロマトグラフ分析装置の制御装置、液体クロマトグラフ分析装置の制御方法、および、液体クロマトグラフ分析システム |
| JPWO2018042529A1 (ja) * | 2016-08-31 | 2019-03-07 | 株式会社島津製作所 | 液体クロマトグラフ分析装置の制御装置、液体クロマトグラフ分析装置の制御方法、および、液体クロマトグラフ分析システム |
| JP2020536252A (ja) * | 2017-10-04 | 2020-12-10 | フジフィルム・ダイオシンス・バイオテクノロジーズ ・ユーケイ・リミテッド | 既定のpHの水溶液を調製するための方法 |
| JP7212681B2 (ja) | 2017-10-04 | 2023-01-25 | フジフィルム・ダイオシンス・バイオテクノロジーズ ・ユーケイ・リミテッド | 既定のpHの水溶液を調製するための方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE264129T1 (de) | 2004-04-15 |
| EP0883428A1 (en) | 1998-12-16 |
| WO1997031692A1 (en) | 1997-09-04 |
| EP0883428B1 (en) | 2004-04-14 |
| DE69728656T2 (de) | 2005-04-28 |
| SE9600796D0 (sv) | 1996-02-29 |
| DE69728656D1 (de) | 2004-05-19 |
| US6221250B1 (en) | 2001-04-24 |
| DK0883428T3 (da) | 2004-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000506968A (ja) | 液体混合物の製造法 | |
| EP2585887B1 (en) | Method of preparing liquid mixtures | |
| Farsang et al. | Tuning selectivity in cation-exchange chromatography applied for monoclonal antibody separations, part 1: Alternative mobile phases and fine tuning of the separation | |
| US7790025B2 (en) | External gradient chromatofocusing | |
| Dolan et al. | Reversed-phase liquid chromatographic separation of complex samples by optimizing temperature and gradient time: III. Improving the accuracy of computer simulation | |
| Zhang et al. | Improving pH gradient cation-exchange chromatography of monoclonal antibodies by controlling ionic strength | |
| US9446329B2 (en) | Preparation of liquid mixtures | |
| Lingg et al. | Highly linear pH gradients for analyzing monoclonal antibody charge heterogeneity in the alkaline range | |
| WO2011037530A1 (en) | Method and system for preparation of liquid mixtures | |
| EP2433952A1 (en) | Liquid chromatography system and method for protein separation and purification | |
| Müller-Späth et al. | Model simulation and experimental verification of a cation-exchange IgG capture step in batch and continuous chromatography | |
| Farsang et al. | Impact of the column on effluent pH in cation exchange pH gradient chromatography, a practical study | |
| JP2025029052A (ja) | 予測される溶出緩衝液の塩濃度を使用するカチオンクロマトグラフィー | |
| Guo et al. | Development of chromatofocusing techniques employing mixed-mode column packings for protein separations | |
| WO2011149872A1 (en) | Process for preparing liquid mixtures of known ph and salt concentration | |
| Nitika et al. | Continuous manufacturing of monoclonal antibodies: Dynamic control of multiple integrated polishing chromatography steps using BioSMB | |
| JPH0618504A (ja) | 高速液体クロマトグラフィーによる測定値の安定化方法 | |
| Feng et al. | Simultaneous quantification of proteins in human serum via sulfur and iron using HPLC coupled to post-column isotope dilution mass spectrometry | |
| Zisi et al. | Retention modeling in combined pH/organic solvent gradient reversed-phase HPLC | |
| US11175266B2 (en) | Methods for preparing liquid mixtures | |
| Pappa-Louisi et al. | Optimisation of multilinear gradient elutions in reversed-phase liquid chromatography using ternary solvent mixtures | |
| Isaksson et al. | Autonomous operation and quality monitoring of a continuous antibody downstream process | |
| Whitley et al. | Nonlinear gradient isotherm parameter estimation for proteins with consideration of salt competition and multiple forms | |
| Nielsen | Simulated evolutionary optimization of an ion-exchange chromatography step | |
| Snyder et al. | Computer simulation as a tool for optimizing gradient separations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040217 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040217 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050927 |
|
| A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20060213 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060328 |